Guardian Pharmacy Services Expands Pacific Northwest Footprint with Acquisition of Washington-based Mercury Pharmacy Services
ATLANTA–(BUSINESS WIRE)–Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s largest and most innovative long-term care (LTC) pharmacy... Read more.
Mary Campbell Joins Alliant Insurance Services’ Northwest Benefits Team
Veteran benefits consultant has deep expertise in alternative funding strategies for large, multi-state employers IRVINE, Calif.–(BUSINESS WIRE)–#AlliantInsurance–Mary... Read more.
Datavault AI to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3 – Thursday, June 5 at 9:00 a.m. EDT
Company fireside chat on June 4, at 1:00 p.m. EDT BEAVERTON, Ore.–(BUSINESS WIRE)–Datavault AI Inc. (NASDAQ: DVLT), leading the way in AI data experience,... Read more.
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab reduced the risk of disease progression or death by 44% vs. THP as 1st-line therapy in patients with HER2-positive metastatic breast cancer in DESTINY-Breast09 Phase III trial
AstraZeneca and Daiichi Sankyo’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three years First trial in more than a decade to... Read more.
Adtran expands Oscilloquartz atomic clock portfolio with lower-cost optical cesium solutions for wider market adoption
News summary: New Oscilloquartz models bring advanced optical pumping technology to telecom, defense, data center and metrology networks Adtran’s unique cesium... Read more.
ARDRI Welcomes Christine Lacy as VP of Wholesale Production—Already Shaping the Future of Non-QM Lending
CALABASAS, Calif.–(BUSINESS WIRE)–#ARDRI–ARDRI, a technology-driven non-QM and Business Purpose lender, is excited to welcome Christine Lacy as... Read more.
AEye’s Apollo Lidar Sensor Wins Prestigious AIIA Intelligent Perception Industry Leadership Award
PLEASANTON, Calif.–(BUSINESS WIRE)–AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, announced today that its... Read more.
ENHERTU® Plus Pertuzumab Reduced the Risk of Disease Progression or Death by 44% Versus THP as First-Line Therapy in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast09 Phase 3 Trial
Daiichi Sankyo and AstraZeneca’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three years First trial in more than a decade to... Read more.
Nebius Group announces private placement of $1 billion in aggregate principal amount of convertible notes
AMSTERDAM–(BUSINESS WIRE)–Nebius Group N.V. (“Nebius Group” or the “Company”; NASDAQ: NBIS), a leading AI infrastructure company, today announced... Read more.
How to Maximise the IP in your Business: Building and Managing a Patent Portfolio to Best Support your Business Training Course (ONLINE EVENT: July 3, 2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Building and Managing a Patent Portfolio to Best Support your Business Training Course” training has been added... Read more.